DNA methylation signatures from peripheral blood revealed epigenetic alterations in Fanconi anemia
Human Genetics · 2026-12 · 145 (1)
DOI: 10.1007/s00439-026-02827-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Genetics, online erschienen am 27.03.2026. Verfasst von Merin George und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytogenetics, ICMR-National Institute of Immunoheamatology, K.E.M. Hospital Campus, Parel, Mumbai, 400 012, Maharashtra, India. Hauptthemen laut MEDLINE: Fanconi Anemia, DNA Methylation, Epigenesis, Genetic. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Fanconi Anemia (FA) is a rare autosomal recessive disorder; characterized by bone marrow failure, congenital malformation, and a markedly increased risk of cancers. Despite well characterized genetic defects in the FA/BRCA pathway, the mechanisms underlining variable disease severity and cancer susceptibility remains unknown. We studied the role of global DNA methylation and its implication in the cancer predisposition in FA. Chromosomal breakage analysis from peripheral blood cultures induced with Mitomycin C. Mutational analysis using NGS, MLPA and Sanger sequencing. Genome-wide DNA methylation profiling was performed using Illumina Infinium Methylation EPIC 850k Bead Chip Array and gene expression was validated by qPCR. Global DNA methylation profiling revealed a significant hyper-methylation pattern in FA patients as compared to the controls. Pathway enrichment and gene ontology analysis revealed the hyper-methylated genes were associated with the mTOR, WNT, cell adhesion and non-homologous end joining pathways, while hypo-methylated genes were enriched in NF-kb, MAPK, Calcium and JAK-STAT signalling pathways. Validation of top candidate genes showed significant downregulation of FAM65B, NKAPL, ITGAM, CDIP1 and CDKN1b genes which are involved in tumour suppression, immune regulation and cell-cycle control. Protein-Protein interaction analysis demonstrated that these genes are indirectly linked through the p53 and TNF- α signalling axes, contributing to a pro-inflammatory microenvironment that may promotes the emergence of pre-leukemic clones in FA. These results suggest that aberrant DNA methylation may play a role in cancer predisposition in FA by silencing key regulatory genes and may represent as promising candidates for prediction of cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cytogenetics, ICMR-National Institute of Immunoheamatology, K.E.M. Hospital Campus, Parel, Mumbai, 400 012, Maharashtra, India.
- 1Cell.Ai, Powai, Mumbai, 400076, India.
- Comprehensive Thalassemia Care Center and Bone Marrow Transplantation Center, Mumbai, 400066, Maharashtra, India.
- Department of Pediatric Haematology, Institute of Child Health and Hospital for children, Chennai, 600008, Tamil Nadu, India.
- Usha Hematology Center, Sangli, 416410, Maharashtra, India.
- Bai Jerbai Wadia Hospital for Children, Mumbai, 400012, Maharashtra, India.
Zitieren
APA
George, M., Halder, S., Gowhar, S., Shah, A., Dhangar, S., Ghatanatti, J., Aarthi, R., Kini, P., Mangalani, M., Rajendran, A., Nemani, S., Murlidar, S., & Vundinti, B. R. (2026). DNA methylation signatures from peripheral blood revealed epigenetic alterations in Fanconi anemia. Human Genetics, 145(1). https://doi.org/10.1007/s00439-026-02827-4
Vancouver
George M, Halder S, Gowhar S, Shah A, Dhangar S, Ghatanatti J, et al. DNA methylation signatures from peripheral blood revealed epigenetic alterations in Fanconi anemia. Human Genetics. 2026;145(1). doi:10.1007/s00439-026-02827-4
BibTeX
@article{George2026,
author = {George, Merin and Halder, Sumit and Gowhar, Shafi and Shah, Anjali and Dhangar, Somprakash and Ghatanatti, Jagadeeshwar and Aarthi, Ramesh and Kini, Pranoti and Mangalani, Mamta and Rajendran, Aruna and Nemani, Sandeep and Murlidar, Sangeeta and Vundinti, Babu Rao},
title = {DNA methylation signatures from peripheral blood revealed epigenetic alterations in Fanconi anemia},
journal = {Human Genetics},
year = {2026},
volume = {145},
number = {1},
doi = {10.1007/s00439-026-02827-4}
}
EUVIMED